Serum Institute of India to Manufacture Oxford Ebola Vaccine in Major Global Health Push
The project has received funding support of up to US$8.6 million, giving momentum to the rapid development of the vaccine candidate. The support will help accelerate preclinical work, prepare the vaccine for early-stage human trials, and enable the production of clinical-grade doses. At a time when outbreaks can move quickly across borders, this kind of early manufacturing readiness has become a critical part of epidemic preparedness.